Proton Beam Radiation Therapy After Treatment for Resected N2 Non-Small Cell Lung Cancer

Part of paid clinical trials in Atlanta, Georgia.

Sponsor
Emory University
Study ID
NCT06008730
Phase
PHASE2
Status
Recruiting

Conditions

  • Resectable Lung Non-Small Cell Carcinoma

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Biospecimen Collection — PROCEDURE
    Undergo collection of blood samples
  • Proton Beam Radiation Therapy — RADIATION
    Undergo proton beam radiation therapy
  • Radiology, Treatment Planning — OTHER
    Undergo radiation treatment planning

Study Details

This clinical trial tests proton beam radiation therapy in patients with non-small cell lung cancer who have undergone surgical resection and have lymph nodes involving the middle of the chest. Proton therapy is a type of radiation treatment that kills cancer cells while avoiding surrounding healthy tissue. Proton beam therapy is sometimes used after cancer surgery to reduce the risk of cancer recurrence (coming back). Giving proton beam radiation therapy may work better than conventional radiation treatment after surgery in patients with non-small cell lung cancer.

Key Dates

Start date
Dec 13, 2024
Status verified
Nov 2025
Primary completion
Dec 31, 2026
Completion
Dec 31, 2027

Study Design

Enrollment
20 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Treatment (proton beam radiation therapy)
    Patients undergo radiation treatment planning and then undergo proton beam radiation therapy on study. Patients also undergo collection of blood samples.

Primary Outcome Measure

Incidence of adverse events (AEs) [ Time Frame: Up to 90 days from enrollment ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Emory University Hospital/Winship Cancer InstituteAtlantaGeorgia30322
Tegan VandenBosch
William Stokes, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Atlanta, GA

Related Studies